News Focus
News Focus
Followers 99
Posts 13186
Boards Moderated 0
Alias Born 06/01/2013

Re: bow-tie post# 20204

Monday, 09/14/2020 6:08:38 PM

Monday, September 14, 2020 6:08:38 PM

Post# of 27661
So that everyone is on the same plane

Isn't that interesting, manufacturing about to change here :?

From SP1 so thanks to him for this. I'll add that Gsk is big on liposomes w/ Operation Warp Speed

https://translate.google.com/translate?hl=en&sl=de&u=https://www.diepresse.com/5861311/teil-des-covid-19-impfstoffes-konnte-aus-osterreich-kommen&prev=search&pto=aue

So I added these

In that, check this out

https://www.fitforhealth.eu/cms/docs/Success_stories/Polymun_success_story.pdf

https://www.polymun.com/about-us/

Aint that interesting

from the Polymun link

Polymun started the development of a biosimilar rhFSH (follicle stimulating hormone) in 2006. Together with our license partner Finox AG, the drug product with the name Bemfola® was clinically tested successfully. Finox AG obtained market approval from EMA in April 2014. Since then, several other countries such as Australia, New Zealand and Israel have granted market approval for Bemfola®. Polymun remains the exclusive manufacturer of rhFSH as drug substance.

https://finoxbiotech.com/

nada much there but

Richter announces the acquisition of Finox Holding for a consideration of CHF190 million
6/30/2016

https://www.richter.hu/en-US/investors/announcements/Pages/extraord160630.aspx

https://www.richter.hu/en-US/our-activity/Pages/Pharmaceutical-manufacturing.aspx

https://www.richter.hu/en-US/richter-group/Pages/default.aspx

She's going to turn folks, release the hounds
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y